R. Cameron Wolf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
R. Cameron Wolf has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adrianne R. Wilson-Poe
Legacy Health
1 shared publication - Alissa Bazinet
Sequoia Center, Portland, United States
1 shared publication - Christina Chwyl
Portland Institute for Psychedelic Science, Portland, United States
1 shared publication Ingrid Donato
Substance Abuse and Mental Health Services Administration (SAMHSA)
1 shared publication- Jason B. Luoma
Portland Psychotherapy Clinic, Research, and Training Center, Portland, United States
1 shared publication Joshua S. Hunt
Substance Abuse and Mental Health Services Administration (SAMHSA)
1 shared publication
Latest Publications
- Open Access
- 6 August 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1900601
Priorities for public health preparedness for psychedelics: education, workforce readiness, and strategic information needs in a rapidly changing landscape
Use of psychedelic substances is increasing across unregulated, state-regulated, research, ceremonial/religious, and medical settings in the United States. Concurrently, a growing body of clinical research signals the potential for therapeutic applications for specific psychedelics in the treatment of depression, post-traumatic stress disorder, substance use disorders, and other health conditions. This evolving landscape presents both promise and complexity. From a public health perspective, a structured public health preparedness approach is needed to prioritize safety, workforce readiness, and data infrastructure in a manner that promotes individual and collective well-being while supporting responsible evidence development. This commentary proposes priorities for public health preparedness for psychedelics: (1) education and prevention of adverse events; (2) behavioral health workforce development; and (3) strategic information and data analysis. Educational efforts should emphasize clear risk communication, substance-specific messaging, prevention of adverse events, and practical guidance to support policy decision-making. Workforce considerations include defining core competencies, clarifying ethical boundaries and informed consent, establishing training and technical assistance infrastructure, strengthening capacity across the behavioral health workforce, and preparing providers to respond to patients using psychedelics outside regulated systems. Strategic information priorities include strengthening data systems and improving coordination and harmonization of epidemiologic monitoring related to patterns of use, adverse events, treatment-seeking behaviors, and the implications of evolving policy environments. As psychedelics enter mainstream discourse, public health institutions must adopt a balanced approach that considers both benefits and risks. A proactive, health-promoting, and data-driven framework can help ensure that policies and practices are grounded in safety and core public health principles.
- 6 August 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1900601
Open AccessPriorities for public health preparedness for psychedelics: education, workforce readiness, and strategic information needs in a rapidly changing landscape
Use of psychedelic substances is increasing across unregulated, state-regulated, research, ceremonial/religious, and medical settings in the United States. Concurrently, a growing body of clinical research signals the potential for therapeutic applications for specific psychedelics in the treatment of depression, post-traumatic stress disorder, substance use disorders, and other health conditions. This evolving landscape presents both promise and complexity. From a public health perspective, a structured public health preparedness approach is needed to prioritize safety, workforce readiness, and data infrastructure in a manner that promotes individual and collective well-being while supporting responsible evidence development. This commentary proposes priorities for public health preparedness for psychedelics: (1) education and prevention of adverse events; (2) behavioral health workforce development; and (3) strategic information and data analysis. Educational efforts should emphasize clear risk communication, substance-specific messaging, prevention of adverse events, and practical guidance to support policy decision-making. Workforce considerations include defining core competencies, clarifying ethical boundaries and informed consent, establishing training and technical assistance infrastructure, strengthening capacity across the behavioral health workforce, and preparing providers to respond to patients using psychedelics outside regulated systems. Strategic information priorities include strengthening data systems and improving coordination and harmonization of epidemiologic monitoring related to patterns of use, adverse events, treatment-seeking behaviors, and the implications of evolving policy environments. As psychedelics enter mainstream discourse, public health institutions must adopt a balanced approach that considers both benefits and risks. A proactive, health-promoting, and data-driven framework can help ensure that policies and practices are grounded in safety and core public health principles.
- Open Access
- 13 May 2026
- Published by Springer Nature in Neuroethics
- Vol. 19 (2) , 21
Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study
- 13 May 2026
- Published by Springer Nature in Neuroethics
- Vol. 19 (2) , 21
Open AccessEthical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study